Vall d’Hebron Institute of Oncology - Breast Cancer

We have generated an extensive experimental resource of PDXs from primary and metastatic breast tumours, aiming to tackle drug resistances and find new therapies.

The Vall d’Hebron Institute of Oncology is a member of the EurOPDX Consortium. EurOPDX is supported by the European Union's Horizon 2020 research and innovation program under the grant agreement No. 731105 EDIReX